Furthermore, a humanised anti-RAGE mAb protected mice from pneumonia-induced mortality29, thus suggesting the notion that direct RAGE antagonism could be a promising therapeutic target in lung injury28. The gene discussed is AGER; the disease is susceptibility to pneumonia measurement.